No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors

被引:37
|
作者
Rietbergen, Michelle M. [1 ]
Braakhuis, Boudewijn J. M. [1 ]
Moukhtari, Nadia [1 ]
Bloemena, Elisabeth [2 ,3 ]
Brink, Arjen [1 ]
Sie, Daoud [3 ]
Ylstra, Bauke [3 ]
de Jong, Robert J. Baatenburg [4 ]
Snijders, Peter J. F. [3 ]
Brakenhoff, Ruud H. [1 ]
Leemans, C. Rene [1 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Dept Otolaryngol Head & Neck Surg, NL-1007 MB Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Acad Ctr Dent Amsterdam ACTA, Dept Oral & Maxillofacial Surg, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands
[4] Erasmus MC, Dept Otolaryngol Head & Neck Surg, Rotterdam, Netherlands
关键词
SQUAMOUS-CELL CARCINOMA; 2ND PRIMARY TUMORS; GENETICALLY ALTERED FIELDS; NECK-CANCER PATIENTS; CLINICAL-IMPLICATIONS; COPY NUMBER; ARRAY CGH; HEAD; CANCERIZATION; PREVALENCE;
D O I
10.1111/jop.12123
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: Patients with human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinomas (OPSCCs) have a better prognosis than patients with HPV-negative OPSCCs. Important factors contributing to this better prognosis are relatively low numbers of local/regional recurrences (LRRs) and second primary tumors (SPTs) in patients with HPV-positive OPSCC. These low numbers may be explained in addition by the absence of a 'field cancerization' effect, which is a cause of LRRs and SPTs in patients with HPV-negative OPSCC. We aimed to detect a possible 'field effect' in patients with HPV-positive OPSCC. As HPV is involved in the early stage of carcinogenesis in OPSCCs, its presence is considered a reliable marker for the detection of such a field effect. Therefore, the presence of transcriptionally active HPV was analyzed in the mucosa surrounding HPV-positive OPSCCs. Methods: We included 20 patients who were surgically treated for an HPV-positive OPSCC in the period 2000-2006. Of each patient, the formalin-fixed paraffin-embedded tumor sample and all available resection margins were collected. In total, 97 resection margins were investigated with an average of five resection margins per tumor. All samples were analyzed for the presence of tumor and the presence of transcriptionally active HPV by HPV16-E6-mRNA detection. Results: All tumors were HPV16-E6-mRNA positive. HPV16-E6-mRNA could be detected in the resection margins that contained tumor (n = 6). All tumor-negative resection margins (n = 91) scored negative for HPV16-E6-mRNA. Conclusions: In conclusion, transcriptional active HPV could not be detected in the mucosa surrounding an HPV-positive OPSCC, which suggests the absence of field effect. This observation may explain the lower number of LRRs and SPTs in HPV-positive patients. © 2013 John Wiley & Sons A/S.
引用
收藏
页码:137 / 142
页数:6
相关论文
共 50 条
  • [21] Radiochemotherapy of HPV-positive oropharyngeal carcinomas: Cisplatin is still to be prioritizede
    Clement-Colmou, Karen
    BULLETIN DU CANCER, 2020, 107 (03) : 293 - 294
  • [22] Influence of sex on survival rates of HPV-positive oropharyngeal cancers
    Preissner, Sally H.
    Nahles, Susanne
    Preissner, Saskia
    Heiland, Max
    Koerdt, Steffen
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [23] Surgical Margin Determination in the Era of HPV-Positive Oropharyngeal Cancer
    Pool, Christopher
    Weaver, Taelor
    Zhu, Junjia
    Goldenberg, David
    Goyal, Neerav
    LARYNGOSCOPE, 2021, 131 (10): : E2650 - E2654
  • [24] HPV-Positive Oropharyngeal Carcinoma: A Systematic Review of Treatment and Prognosis
    Wang, Marilene B.
    Liu, Isabelle Y.
    Gornbein, Jeffrey A.
    Nguyen, Chau T.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2015, 153 (05) : 758 - 769
  • [25] Genetic and epigenetic analysis of HPV-positive and HPV-negative Oropharyngeal squamous cell carcinoma
    Nakagawa, Takuya
    Matsusaka, Keisuke
    Misawa, Kiyoshi
    Fukuyo, Masaki
    Kurokawa, Tomoya
    Mima, Masato
    Matsubara, Hisahiro
    Hanazawa, Toyoyuki
    Kaneda, Atsushi
    CANCER RESEARCH, 2020, 80 (16)
  • [26] Oral health in HPV-positive and HPV-negative patients with oropharyngeal squamous cell carcinoma
    Kanzow, Philipp
    Mielke, Katharina
    Hrasky, Valentina
    Wiegand, Susanne
    Schliephake, Henning
    Beutner, Dirk
    Wiegand, Annette
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [27] Presenting symptoms and clinical findings in HPV-positive and HPV-negative oropharyngeal cancer patients
    Carpen, Timo
    Sjoblom, Anni
    Lundberg, Marie
    Haglund, Caj
    Markkola, Antti
    Syrjanen, Stina
    Tarkkanen, Jussi
    Makitie, Antti
    Hagstrom, Jaana
    Mattila, Petri
    ACTA OTO-LARYNGOLOGICA, 2018, 138 (05) : 513 - 518
  • [28] HPV Structure and Integration Impact the Genomic Profile of HPV-Positive Oropharyngeal Squamous Cell Carcinoma
    Mazul, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1313 - 1313
  • [29] Circulating Tumor HPV-DNA in the Management of HPV-Positive Oropharyngeal Carcinoma: A Systematic Review
    Chen, Allen M.
    Tjoa, Tjoson
    Armstrong, William B.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2025,
  • [30] The impact of HPV genotypes on survival in HPV-positive oropharyngeal squamous cell carcinomas: a systematic review
    Skovvang, Anne
    Jensen, Jakob Schmidt
    Garset-Zamani, Martin
    Carlander, Amanda
    Gronhoj, Christian
    von Buchwald, Christian
    ACTA OTO-LARYNGOLOGICA, 2021, 141 (07) : 724 - 728